Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury

Journal of Cell Biology

Volumn 149, Issue 5, 2000, Pages 1157-1166

  Akassoglou, Katerina ^a   Kombrinck, Keith W ^b   Degen, Jay L ^b   Strickland, Sidney ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Ancrod; Coagulation; Extracellular matrix; Proteolysis; Schwann cells

Indexed keywords

FIBRIN; LAMININ; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEMYELINATION; DISEASE EXACERBATION; FIBRINOLYSIS; GENE EXPRESSION; GENE INDUCTION; MOUSE; NERVE CELL NECROSIS; NERVE FIBER DEGENERATION; NERVE INJURY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SCIATIC NERVE;

ANIMALS; AXONS; BLOOD COAGULATION; DEMYELINATING DISEASES; EXTRACELLULAR MATRIX; FIBRIN; FIBRINOGEN; FIBRINOLYSIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE DENERVATION; MUSCLE, SKELETAL; NERVE DEGENERATION; PLASMINOGEN; SCHWANN CELLS; SCIATIC NERVE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMALIA;

EID: 0034729210     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.149.5.1157     Document Type: Article

References (60)

1. Akassoglou, K., L. Probert, G. Kontogeorgos, and G. Kollias. 1997. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J. Immunol. 158:438-445.
2. Akassoglou, K., J. Bauer, G. Kassiotis, M. Pasparakis, H. Lassmann, G. Kollias, and L. Probert. 1998. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am. J. Pathol. 153:801-813.
3. Akenami, F.O., M. Koskiniemi, M. Farkkila, and A. Vaheri. 1997. A. cerebrospinal fluid plasminogen activator inhibitor-1 in patients with neurological disease. J. Clin. Pathol. 50:157-160.
4. Akenami, F.O., V. Siren, M. Wessman, M. Koskiniemi, and A. Vaheri. 1999. Tissue plasminogen activator gene expression in multiple sclerosis brain tissue. J. Neurol. Sci. 165:71-76.
5. Arnold, D.L. 1999. Magnetic resonance spectroscopy: imaging axonal damage in MS. J. Neuroimmunol. 98:2-6.
6. Bell, W.R., S.S. Shapiro, J. Marinez., and H.L. Nossel. 1978. The effects of ancrod, the coagulating enzyme from the venom of Malayan pit viper (A. rhodostoma) on prothrombin and fibrinogen metabolism and fibrinopeptide A release in man. J. Lab. Clin. Med. 91:592-604.
7. Bignami, A., G. Cella, and N.H. Chi. 1982. Plasminogen activators in rat neural tissues during development and in Wallerian degeneration. Acta Neuropathol. 58:224-228.
8. Bridge, P.M., D.J. Ball, S.E. Mackinnon, Y. Nakao, K. Brandt, D.A. Hunter, and C. Hertl. 1994. Nerve crush injuries: a model for axonotmesis. Exp. Neurol. 127:284-290.
9. Bugge, T.H., M.J. Flick, C.C. Daugherty, and J.I., Degen. 1995. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev. 9:794-807.
10. Bugge, T.H., K. W. Kombrinck, M.J. Flick, C.C. Daugherty, M.J. Danton, and J.I. Degen. 1996. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell. 87:709-719.
11. Bush, M.S., A.R. Reid, and G. Allt. 1993. Blood-nerve barrier: ultrastructural and endothelial surface charge alterations following nerve crush. Neuropathol. Appl. Neurobiol. 19:31-40.
12. Busso, N., V. Peclat, K. Van Ness, E. Kolodzieczyk, J. Degen, T. Bugge, and A. So. 1998. Exacerbation of antigen-induced arthritis in urokinase-deficient mice. J. Clin. Invest. 102:41-50.
13. Cammer, W., B.R. Bloom, W.T. Norton, and S. Gordon. 1978. Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. Proc. Natl. Acad. Sci. USA. 75:1554-1558.
14. Carmeliet, P., L. Sehoonjans, L. Kieckens, B. Ream, J. Degen, R. Bronson, R. De Vos, J.J. van den Oord, D. Collen, and R.C. Mulligan. 1994. Physiological consequences of loss of plasminogen activator gene function in mice. Nature. 368:419-424.
15. Castano, A., M.D. Bell, and V.H. Perry. 1996. Unusual aspects of inflammation in the nervous system: Wallerian degeneration. Neurobiol. Aging. 17:745-751.
16. Chen, Z.L., and S. Strickland. 1997. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell. 91:917-925.
17. Chen, Z.L., J.A. Indyk, T.H. Bugge, K.W. Kombrinck, J.L. Degen, and S. Strickland. 1999. Neuronal death and blood-brain harrier breakdown after excitotoxic injury are independent processes. J. Neurosci. 19:9813-9820.
18. Clark, M.B., R. Zeheb, T.K. White, and R.P. Bunge. 1991. Schwann cell plasminogen activator is regulated by neurons. Glia. 4:514-528.
19. Claudio, L., C.S. Raine, and C.F. Brosnan. 1995. Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple selerosis. Acta Neuropathol. 90:228-238.
20. Creange, A., G. Barlovatz-Meimon, and R.K. Gherardi. 1997. Cytokines and peripheral nerve disorders. Eur. Cytokine Net. 8:145-151.
21. Cuzner, M.L., and G. Opdenakker. 1999. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyclination of the central nervous system. J. Neuroimmunol. 94:1-14.
22. Drew, A.F., A.H. Kaufman, K.W. Kombrinck, M.J. Danton, C.C. Daughterly, J.L. Degen, and T.H. Bugge. 1998. Ligneous conjunetivitis in plasminogendeficient mice. Blood. 91:1616-1624.
23. Deutsch, D.G., and E.T. Mertz. 1970. Plasminogen: purification from human plasma by affinity chromatography. Science 170:1095-1096.
24. Formica, S., T.I. Roach, and J.M. Blackwell. 1994. Interaction with extracellular matrix proteins influences Lsh/Ity/Bcg (candidate Nramp) gene regulation of macrophage priming/activation for tumour necrosis factor-alpha and nitrite release. Immunology. 82:42-50.
25. Funakoshi, H., M. Risling, T. Carlstedt, U. Lendahl, T. Timmusk, M. Metsis, Y. Yamamoto, and C.F. Ibanez. 1998. Targeted expression of a multifunctional chimeric neurotrophin in the lesioned sciatic nerve accelerates regeneration of sensory and motor axons. Proc. Natl. Acad. Sci. USA. 95:5269-5274.
26. Hastings, G.A., T.A. Coleman, C.C. Haudenschild, S. Stefansson, E.P. Smith, R. Barthlow, S. Cherry, M. Sandkvist, and D.A. Lawrence. 1997. Neuroserpin. a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival. J. Biol. Chem. 272:13062-33067.
27. Idell, S., K.K. James, E.G. Levin, B.S. Schwartz. N. Manchanda, R.J. Maunder, T.R. Martin, J. McLarty, and D.S. Fair. 1989. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin. Invest. 84:695-705.
28. Kilic, E., D.M. Hermann, and K.A. Hossmann. 1999. Recombinant tissue plasminogen activator reduces infaret size after reversible thread occlusion of middle cerebral artery in mice. Neuroreport 10:107-111.
29. Kim, Y.H., J.H. Park, S.U. Hong, and J.Y. Koh. 1999. Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator. Science. 284:647-650.
30. Kitching, A.R., S.R. Holdsworth, V.A. Ploplis. E.F. Plow, D. Collen, P. Carmeliet, and P.G. Tipping. 1997. Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J. Exp. Med. 185:963-968.
31. Koh, C.S., J. Gausas, and P. Y. Paterson. 1993. Neurovascular permeability and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis in relationship to clinical and histopathological features of the disease. J. Neuroimmunol. 47:141-145.
32. Krystosek, A., and N.W. Seeds. 1984. Peripheral neurons and Schwann cells secrete plasminogen activator. J. Cell Biol. 98:773-774.
33. La Fleur, M., J.L. Underwood, D.A. Rappolee, and Z. Werb. 1996. Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J. Exp. Med. 184:2311-2326.
34. Liberski, P.P., and D.C. Gajdusek. 1997. Myelinated axon undergoes complete demyelination in the panencephalopathic: but it is merely subjected to the Wallerian degeneration in the polioencephalopathic type of transmissible spongiform encephalopathies. Pol. J. Pathol. 48:163-171.
35. McRitchie, D.I., M.J. Girotti, M.F. Glynn, J.M. Goldberg, and O.D, Rotstein. 1991. Effect of systemic fibrinogen depletion on intraabdominal abscess formation. J. Lab. Clin Med. 118:48-55.
36. Nagai, N., M. De Mol, H.R. Lijnen, P. Carmeliet, D. Collen. 1999. Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice. Circulation. 99:2440-2444.
37. Neuberger, T.J., and C.J. Cornbrooks. 1989. Transient modulation of Schwann cell antigens after peripheral nerve transection and subsequent regeneration. J. Neurocytol. 18:695-710.
38. Norton, W.T., C.F. Brosnan, W. Cammer, and E.A. Goldmuntz. 1990. Mechanisms and suppression of inflammatory demyelination. Acta Neurobiol. Exp. 50:225-235.
39. Osterwalder, T., J. Contartese, E.T. Stoeckli, T.B. Kuhn, P. Sonderegger. 1996. Neuroserpin, an axonally secreted serine protease inhibitor. EMBO (Eur. Mol. Biol. Organ.) J. 15:2944-2953.
40. Perez, R.L., and J. Roman. 1995. Fibrin enhances the expression of IL-1 beta by human peripheral blood mononuclear cells. Implications in pulmonary inflammation. J. Immunol. 154:1879-1887.
41. Ploplis, V.A., P. Carmeliet, S. Vazizadeh, I. Van Vlaenderen, L. Moons, E.F. Plow, and D. Collen. 1995. Effects of disruption of the plasminogen gene on thrombosis, growth and health in mice. Circulation. 92:2585-2593.
42. Reich, E. 1978. Activation of plasminogen: a widespread mechanism for generating localized extracellular proteolysis. In Biological Markers of Neoplasia: Basic and Applied Aspects. R.W. Ruddon, edilor. Elsevier North Holland, Inc., Amsterdam, 491-500.
43. Rogove, A.D., C.-J. Siao, D. Keyt, S. Strickland, and S.E. Tsirka. 1999. Activation of microglia reveals a non-proteolytic cytokine function for tissue plasminogen activator in the central nervous system. J. Cell Sci. 112:4007-41116.
44. Said, G., C. Goulon-Goeau, G. Slama, and G. Tchobroutsky. 1992. Severe early-onset polyneuropathy in insulin-dependent diabetes mellitus. A clinical and pathological study. N. Engl. J. Med. 326:1257-1263.
45. Sallés, F.J., N. Schechter, and S. Strickland. 1990. A plasminogen activator is induced during goldfish optic nerve regeneration. EMBO (Eur. Molo. Biol. Organ.) J. 9:2471-2-477.
46. Sappino, A., R. Madani, J. Huarte, D. Belin, J. Kiss, A. Wohlwend, and J.-D. Vassalli. 1993. Extracellular proteolysis in the adult marine brain. J. Clin. Invest. 92:679-685.
47. Sawlani, V., R.K. Gupta, M.K. Singh, and A. Kohli. 1997. MRI demonstration of Wallerian degeneration in various intracranial lesions and its clinical implications. J. Neurol. Sci. 146:103-108.
48. Seeds, N.W., L.B. Siconolfi, and S.P. Haffke. 1997. Neuronal extracellular proteases facilitate cell migration, axonal growth, and pathfinding. Cell Tissue Res. 290:367-370.
49. Suh, T.T., K. Holmback, N.J. Jensen, C.C. Daugherty, K. Small, D.I. Simon, S. Potter, and J.L. Degen. 1995. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev. 9:2020-2033.
50. Tang, L., and J.W, Eaton. 1993. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J. Exp. Med. 178:2147-2156.
51. Trapp, B.D., J. Peterson, R.M. Ransohoff, R. Rudick, S. Mork, and L. Bo. 1998. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338: 278-285.
52. Trojaborg, W. 1998. Acute and chronic neuropathies: new aspects of Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. an overview and an update. Electroencephalogr. Clin. Neurophysiol. 107: 303-316.
53. Tsirka, S.E., A. Gualandris, D.G. Amaral, and S. Strickland. 1995. Excitotoxininduced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature. 377:340-344.
54. Tsirka, S.E., T.H. Bugge, J.L. Degen, and S. Strickland. 1997a. Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. Proc. Natl. Acad. Sci. USA. 94:9779-9781.
55. Tsirka, S.E., A.D. Rogove, T.H. Bugge, J.L., Degen, and S. Strickland. 1997b. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J. Neurosci. 17:543-552.
56. Vassalli, J.-D., and D. Belin. 1987. Amiloride selectively inhibits the urokinasetype plasminogen activator. FEBS (Fed. Eur. Biochem. Soc) Lett. 214:187-191.
57. Waller, E.K., and W.D. Schleuning. 1985. Induction of fibrinolytic activity in HeLa cells by phorhol myristate acetate. Tissue-type plasminogen activator antigen and mRNA augmentation require intermediate protein biosynthesis. J. Biol. Chem. 260:6354-6360.
58. Wang, Y.F., S.E. Tsirka, S. Strickland, P.E. Stieg, S.G. Soriano, and S.A. Lipton. 1998. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat. Med. 4:228-231.
59. Wiemann, B., G.Y. Van, D.M. Danilenko, Q. Yan, C. Matheson, L. Munyakazi, S. Ogenstad, and C.O. Starnes. 1998. Combined treatment of acute EAE in Lewis rats with TNF-binding protein and interleukin-1 receptor antagonist. Exp. Neurol. 149:455-163.
60. Yuguchi, T., E. Kohmura, K. Yamada, H. Otsuki, T. Sakaki, T. Yamashita, M. Nonaka, T. Sakaguchi, A. Wanaka, and T. Hayakawa. 1997. Expression of tPA mRNA in the facial nucleus following facial nerve transection in the rat. Neuroreport. 8:419-422.